Sorrento Therapeutics Inc (SRNE):企業の財務・戦略的SWOT分析

◆英語タイトル:Sorrento Therapeutics Inc (SRNE) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH185554FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Sorrento Therapeutics Inc (SRNE) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sorrento Therapeutics Inc (Sorrento) is a biopharmaceutical company that focuses on developing therapeutics for the treatment of cancer, osteoarthritis pain and autoimmune diseases. The company’s immunotherapy pipeline portfolio comprises of a CD38 CAR-T, CD38 ADC, CD38 DAR-T and Sephrehvir for treatment of cancer. Sorrento is also investigating COVID19 programs which include Coviguard, Covidrops, Covishield among others for the treatment of COVID-19. Its marketed product include, ZTlido, a lidocaine topical system for the treatment of postherpetic neuralgia (PHN). The company works in collaboration with biopharmaceutical companies and academic institutions to develop novel immunotherapies. Sorrento is headquartered in San Diego, California, the US.

Sorrento Therapeutics Inc Key Recent Developments

Apr 05,2021: Sorrento Enters Into Merger Agreement to Acquire Late-Stage Oncology Company ACEA Therapeutics
Mar 05,2021: Dr. Henry Ji to Participate in the H.C. Wainwright Virtual GLOBAL LIFE SCIENCES CONFERENCE 2021 Investor Conference
Feb 08,2021: Sorrento announces subsidiary company – ADNAB – to develop and commercialize ADNAB platform products for hematological malignancies and solid tumors based on an exclusive technology license from the Mayo Clinic
Oct 16,2020: Sorrento Therapeutics to purchase ACEA Therapeutics
Oct 09,2020: Sorrento COVID-19 R&D October 13, 2020 Pipeline Call Details Released

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Sorrento Therapeutics Inc – Key Facts
Sorrento Therapeutics Inc – Key Employees
Sorrento Therapeutics Inc – Key Employee Biographies
Sorrento Therapeutics Inc – Major Products and Services
Sorrento Therapeutics Inc – History
Sorrento Therapeutics Inc – Company Statement
Sorrento Therapeutics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Sorrento Therapeutics Inc – Business Description
Business Segment: Scilex
Overview
Performance
Business Segment: Sorrento Therapeutics
Overview
Performance
R&D Overview
Sorrento Therapeutics Inc – Corporate Strategy
Sorrento Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Sorrento Therapeutics Inc – Strengths
Sorrento Therapeutics Inc – Weaknesses
Sorrento Therapeutics Inc – Opportunities
Sorrento Therapeutics Inc – Threats
Sorrento Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Sorrento Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sorrento Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Sorrento Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 05, 2021: Dr. Henry Ji to Participate in the H.C. Wainwright Virtual GLOBAL LIFE SCIENCES CONFERENCE 2021 Investor Conference
Feb 08, 2021: Sorrento announces subsidiary company – ADNAB – to develop and commercialize ADNAB platform products for hematological malignancies and solid tumors based on an exclusive technology license from the Mayo Clinic
Oct 09, 2020: Sorrento COVID-19 R&D October 13, 2020 Pipeline Call Details Released
Oct 04, 2020: Sorrento to host a R&D day to showcase covid-19 product pipeline
Sep 28, 2020: Sorrento releases preclinical data for STI-1499 (COVI-Guard) and STI-2020 (COVI-AMG), potent neutralizing antibodies against SARS-CoV-2
Aug 21, 2020: Sorrento to merge with gene-encoded therapies firm SmartPharm
Aug 18, 2020: Sorrento Therapeutics : Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
Jun 12, 2020: Sorrento announces full repayment of outstanding term loans
May 11, 2020: Sorrento, Mount Sinai to develop antibody cocktail against Covid-19
Apr 30, 2020: Sorrento Therapeutics took $2-5 million PPP government loan for COVID-19-struck small businesses, FOIA request shows
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Sorrento Therapeutics Inc, Key Facts
Sorrento Therapeutics Inc, Key Employees
Sorrento Therapeutics Inc, Key Employee Biographies
Sorrento Therapeutics Inc, Major Products and Services
Sorrento Therapeutics Inc, History
Sorrento Therapeutics Inc, Subsidiaries
Sorrento Therapeutics Inc, Joint Venture
Sorrento Therapeutics Inc, Key Competitors
Sorrento Therapeutics Inc, Ratios based on current share price
Sorrento Therapeutics Inc, Annual Ratios
Sorrento Therapeutics Inc, Annual Ratios (Cont...1)
Sorrento Therapeutics Inc, Annual Ratios (Cont...2)
Sorrento Therapeutics Inc, Interim Ratios
Sorrento Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sorrento Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Sorrento Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Sorrento Therapeutics Inc (SRNE):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CHC Group Ltd (HELIQ)-石油・ガス分野:企業M&A・提携分析
    Summary CHC Group Ltd. (CHC) is a commercial operator of medium and heavy helicopters that provides mission-critical services, search and rescue services, emergency and medical services, maintenance repair and overhauling services, helicopter parts sales and distribution, integrated logistics suppor …
  • Cincinnati Bell Inc (CBB):企業の財務・戦略的SWOT分析
    Cincinnati Bell Inc (CBB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Hotel Grand Central Limited:企業の戦略・SWOT・財務情報
    Hotel Grand Central Limited - Strategy, SWOT and Corporate Finance Report Summary Hotel Grand Central Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Flipkart Internet Private Limited:企業のM&A・事業提携・投資動向
    Flipkart Internet Private Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Flipkart Internet Private Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Barrick Gold Corp:企業の戦略・SWOT・財務情報
    Barrick Gold Corp - Strategy, SWOT and Corporate Finance Report Summary Barrick Gold Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Essentra Plc (ESNT):企業の財務・戦略的SWOT分析
    Essentra Plc (ESNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Nippon Suisan Kaisha, Ltd.
    Nippon Suisan Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Suisan Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Abbott Diabetes Care Inc:医療機器:M&Aディール及び事業提携情報
    Summary Abbott Diabetes Care Inc (ADC), formerly TheraSense Inc, a subsidiary of Abbott Laboratories, is a medical device company that discovers, develops, manufactures, and markets pharmaceuticals and medical products for personal use and hospital use. The company’s products include glucose monitor …
  • SNC-Lavalin Group Inc.:企業の戦略・SWOT・財務分析
    SNC-Lavalin Group Inc. - Strategy, SWOT and Corporate Finance Report Summary SNC-Lavalin Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • OPG Power Ventures Plc (OPG):企業の財務・戦略的SWOT分析
    OPG Power Ventures Plc (OPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Bukwang Pharm Co Ltd (003000):製薬・医療:M&Aディール及び事業提携情報
    Summary Bukwang Pharm Co Ltd (Bukwang Pharmaceutical) is a pharmaceutical company that develops new drugs and pharmaceutical products. The company’s products portfolio includes dexid, thioctacid, levovir, legalon, Orfil, azeptin, lonasen, ixel, and asima, among others. Its pipeline products comprise …
  • IQVIA Holdings Inc (IQV):企業の財務・戦略的SWOT分析
    IQVIA Holdings Inc (IQV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Rompetrol Rafinare SA (RRC):企業の財務・戦略的SWOT分析
    Rompetrol Rafinare SA (RRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Eni SpA Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Eni SpA Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Eni SpA (Eni) is an integrated oil and gas company. The company carries out oil and natural gas exploration, field development and production activities. It also involved in supply, trading and shipping of n …
  • Genomic Vision SA (GV):医療機器:M&Aディール及び事業提携情報
    Summary Genomic Vision (Genomic) is a molecular diagnostics and technology company that develops and commercializes diagnostic tests for genetic diseases and cancers. The company’s portfolio comprises tests for breast cancer and colon cancer, diagnostic solution for facio-scapulo-humeral muscular dy …
  • Mallinckrodt, LLC-製薬・医療分野:企業M&A・提携分析
    Summary Mallinckrodt LLC (Mallinckrodt), a subsidiary of Mallinckrodt Plc is a biophramaceutical company that develops medicines. The company manufactures, markets and distributes generic and specialty pharmaceuticals, active pharmaceutical ingredients, diagnostic imaging agents, global medical imag …
  • Gencor Industries Inc (GENC):企業の財務・戦略的SWOT分析
    Gencor Industries Inc (GENC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Totally Plc (TLY):企業の財務・戦略的SWOT分析
    Summary Totally plc (Totally) is a healthcare service provider that offers positive health and financial solutions. The center designs, implements and delivers coaching services to the healthcare sector, and supports individuals to better understand their healthcare options. It offers treatments and …
  • Southern Petrochemical Industries Corp Ltd (SPIC):企業の財務・戦略的SWOT分析
    Summary Southern Petrochemical Industries Corp Ltd (SPIC) is a chemical company that manufactures fertilizers for agriculture. The company offers products such as chemical fertilizer, organic and water soluble fertilizers, plant growth regulators, micro nutrients, and industrial products. Its chemic …
  • Florida Keys Electric Cooperative Association, Inc.:企業の戦略的SWOT分析
    Florida Keys Electric Cooperative Association, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key compe …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆